The Journal of Urology · 1999 · Unverified reference
Unverified citation — not used by the AI instructor.
Limitations: Bibliographic match not independently verified. Not used as support for clinical benefit.
Explore the library
Insufficient evidenceNonselective melanocortin receptor agonist
Melanotan II
Melanotan II is a synthetic melanocortin analog associated with pigmentation and historical sexual-function research. It is not an FDA-approved tanning medication.
Also indexed as: MT-II
A clear starting point
Melanotan II is a synthetic melanocortin analog associated with pigmentation and historical sexual-function research. It is not an FDA-approved tanning medication.
Systems mapping shows biological relevance, not a treatment recommendation or a patient CPI score.
No validated chemical structure is displayed in this edition.
How it works
Melanocortin signaling
Melanotan II is a synthetic melanocortin analog associated with pigmentation and historical sexual-function research. It is not an FDA-approved tanning medication.
- Targets & processes
- Melanocortin signaling
- Systems & tissues
- See the pathway description; category links describe research relevance, not demonstrated treatment effects.
What does the evidence show?
Pigmentation and historical sexual-function research.
What this does not establish
The reference citation could not be independently matched in this edition. FDA safety information is linked; cosmetic efficacy and long-term safety are not established.
Citation metadata from PubMed, a service of the U.S. National Library of Medicine, NIH. A citation match is not a guarantee of study quality. Abstracts are not full-text reviews.
Safety is a separate question
Serious case reports include priapism, neurological syndromes and melanoma; case reports do not establish causality. Changes in skin lesions warrant medical evaluation. Tanning does not ensure UV protection.
Contraindications & cautions
Not an exhaustive contraindication review. Serious case reports include priapism, neurological syndromes and melanoma; case reports do not establish causality. Changes in skin lesions warrant medical evaluation. Tanning does not ensure UV protection.
Medication & supplement interactions
Interaction information is incomplete. Serious case reports include priapism, neurological syndromes and melanoma; case reports do not establish causality. Changes in skin lesions warrant medical evaluation. Tanning does not ensure UV protection.
Regulatory status · United States
Not FDA-approved. No FDA-approved finished drug for this molecule is identified in this edition. Investigational use, published research or compounding does not establish FDA approval.
Read the official sourceThis is not an exhaustive safety list. Regulatory status varies by jurisdiction and product; investigational use is not approval.
Make the science interactive
A dedicated lesson has not been published for this ingredient yet. Explore the cited profile or ask the instructor.
Your scientific classroom
Ask the IW Science Instructor
Basic level · Published sources only · AI evidence check
Ask about general science. Do not enter names, personal health details or medication lists. This is not a clinical consultation. Discussion stays in this browser’s private learning session for up to 90 days.
All medications and therapies discussed are for educational purposes only. Prescriptions are determined independently by the licensed clinician following a medical evaluation. There is no guarantee that any medication or peptide will be prescribed.
IW Interactive Learning Engine · Adapted from stable OpenMAIC v1.2.1. Open-source license
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.
Education only. Confidence labels are not formal systematic evidence grades. No patient record is used.